Cleared Traditional

K181196 - Caretaker Remote Display App and Careta...

K181196 is an FDA 510(k) clearance for Caretaker Remote Display App and Careta..., manufactured by Caretaker Medical, LLC. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K181196 · Caretaker Medical, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
149d
Days
Class 2
Risk

K181196 is an FDA 510(k) clearance for the Caretaker Remote Display App and Caretaker Software Library. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Caretaker Medical, LLC (Charlottesville, US). The FDA issued a Cleared decision on October 3, 2018 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Caretaker Medical, LLC devices

FDA 510(k) Submission Details - K181196

510(k) Number K181196 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2018
Decision Date October 03, 2018
Days to Decision 149 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 125d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 73
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K181196.
VitalConnect Platform, VitalPatch Biosensor
K183078 · Vitalconnect, Inc. · Mar 2019
Surveyor S2
K182297 · Mortara Instrument, Inc. · Jan 2019
Comarch e-Care Platform
K181248 · Comarch Healthcare SA · Oct 2018
LifeSignals WiPoint Biosensor_iOS Receiver_App System (LifeSignals WiPatch & WiApp System)
K172011 · Hmicro, Inc. · Jun 2018
ScioCardio ECG Transmitter
K171019 · Synergen Technology Labs, LLC · May 2018
BioStamp nPoint
K173510 · Mc10, Inc. · May 2018